Medical Device Industry : Opportunities for Innovation

Panels:

Dr. Hyzan, OSA Technology

Dr Hyzan is an orthopaedic surgeon and currently practising at the Sunway Medical Center. He also is an Associate Professor in Hospital Universiti Kebangsaan Malaysia (HUKM) under Orthopaedics Department. Involve in humanitarian and relief works in Malaysia and various countries such as Pakistan, Syria, Indonesia, Afghanistan and more to help during important disaster.

He is the CEO of OSA Technology Sdn Bhd, a company that producing locally the basic trauma products such as orthopaedic trauma implants and instrumental sets. Having their own manufacturing plant is a real advantage because they acquire the learning processes to produce the best quality products.

Puan Salbiah, MDA

Puan Salbiah Binti Yaakop graduated with a BSc in Biomedical Engineering from Marquette University, USA in 1992.  She has more than 27 years of working experience.  She is currently the Senior Principal Assistant Director in the Guidelines Division of Medical Device Authority.  Here, her main functions are development of policies, guidance documents, guidelines, regulatory documents; managing international affairs and inter-agency agenda, industry assistance, events and specific projects: performing registration and licensing evaluations and verifications; and giving trainings and consultancy.

She is currently the Chairperson of various Guidance Document Development Committees in Medical Device Authority, and AHWP WG & Chair on Standards for Medical Devices.  She is also a member of various Industry Standards Committees, Technical Committees, and Working Groups related to medical devices in the national standards system.

Ts. Dr. Ng Sing Kwei, VP Cradle

Dr. Ng is well experienced in the translation of R&D investment into revenues. He is analytical, creative and is well experienced in early stage investment, technology evaluation, market due diligence and facilitation of commercialisation activities. A graduate from Manchester Metropolitan University, Dr. Ng has more than 13 years’ experience in innovation and technology investment.

As the Vice President of Strategy & Investment, Dr. Ng holds overall responsibility in assessing organizational performance, developing achievable goals and implementing processes that improve organizational effectiveness and build a sustainable competitive advantage. He is also equally responsible for a multitude of responsibilities under Cradle investment portfolio.

Before joining Cradle, he was the Head of Technology Commercialisation at PlaTCOM Ventures Sdn Bhd, a wholly owned subsidiary of Agensi Inovasi Malaysia (AIM). He managed a national funding programme for SMEs, overseeing a portfolio of RM 100 Million commercialisation fund under PlaTCOM. He also led the consultancy and capacity building division. He administered the evaluation of new technologies through technical & market due diligence, identification of investment risks and business planning analysis.

Dr. Ng is a Registered Technology Transfer Professional (RTTP). He is well experienced in grasping technology and business concepts quickly and helps translate them into practical commercial solutions that are commercially viable. He focused on providing essential services nationwide to commercialise technologies developed by local universities, other federal agencies as well as private entities.

Before returning to Malaysia, Dr. Ng worked as a Knowledge Transfer Associate under the Knowledge Transfer Network (KTN) in the UK. Dr. Ng holds a PhD in Microwave Instrumentation from Manchester Metropolitan University (United Kingdom) and a Bachelor of Electronic & Telecommunication Engineering from Universiti Teknologi Malaysia (UTM).
 

Prof. Ir. Dr. Fatimah Ibrahim, CIME

She was the founder and currently the advisor of the Center for Innovation in Medical Engineering (CIME), as well as the former director of the University of Malaya Centre of Innovation and Commercialization (UMCIC). Under her leadership, she introduced UM Deep Tech (UMDT) UMCIC program and nurtured 14 research towards university spin-off company. She received training on commercialization and technology transfer from Oxentia Oxford’s Global Innovation Consultancy and University of Cambridge Enterprise and the University of Nottingham. She owns 18 Intellectual Property Rights; and two of her Patents have been commercialized. Her SMARTMF innovation received Malaysia Commercialization Award (MCY) in 2020, and UM Excellence Awards (ACUM) in 2019. In fact, she has delivered many talks on technology transfer. She was the consultant for leaders on innovation under the Technology Transfer Implementation program organized by the Royal Academy of Engineering, United Kingdom. 

Moderator : Dr. Mas Sahidayana Mokhtar